BI 765423
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for BI 765423, covering 2025-06-25 to 2026-04-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) With or Without Standard Treatment [Phase 2]